Cyclic peptide conjugate of curcumin and doxorubicin as an anticancer agent
Authors:
- Shaban DarwishSDShaban Darwish
- Saghar MozaffariSMSaghar Mozaffari
- Keykavous ParangKPKeykavous Parang
- Rakesh TiwariRTRakesh Tiwari
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 58 (49) , 4617-4622
Abstract
No abstract availableFunding Information
- Chapman University
This publication has 37 references indexed in Scilit:
- Improving antioxidant and antimicrobial properties of curcumin by means of encapsulation in gelatin through electrohydrodynamic atomizationFood Hydrocolloids, 2017
- Understanding curcumin-induced modulation of protein aggregationInternational Journal of Biological Macromolecules, 2017
- Enzyme-assisted ionic liquid extraction of bioactive compound from turmeric (Curcuma longa L.): Isolation, purification and analysis of curcuminIndustrial Crops and Products, 2017
- Doxorubicin enhances curcumin’s cytotoxicity in human prostate cancer cells in vitro by enhancing its cellular uptakeInternational Journal of Pharmaceutics, 2016
- Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcuminBiomedicine & Pharmacotherapy, 2015
- Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapyCancer Letters, 2015
- Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled TrialPhytotherapy Research, 2013
- Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot StudyClinical Cancer Research, 2011
- Dermal wound healing processes with curcumin incorporated collagen filmsBiomaterials, 2004
- Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric ( Curcuma longa )The Journal of Alternative and Complementary Medicine, 2003